Extended release lipophilic indomethacin microspheres:: formulation factors and mathematical equations fitted drug release rates

被引:63
作者
Karasulu, E [1 ]
Karasulu, HY
Ertan, G
Kirilmaz, L
Güneri, T
机构
[1] Univ Ege, Fac Pharm, Dept Biopharmaceut & Pharmacokinet, TR-35100 Izmir, Turkey
[2] Univ Ege, Fac Pharm, Dept Pharmaceut Technol, TR-35100 Izmir, Turkey
关键词
equation; extended release; kinetic model; indomethacin; indomethacin microsphere; lipophilic microsphere;
D O I
10.1016/S0928-0987(03)00048-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Extended release liphophilic microspheres of indomethacin were prepared using cetostearyl alcohol (CsA), stearyl alcohol (SA) and cetyl alcohol (CA) in the various drug-lipid ratios. The release of indometacin was studied on the basis of USP criteria and the effects of drug-lipid ratio, the size of microspheres and carboxymethylcellulose sodium (CMC-Na) added as a hydrophilic polymer on the drug release were investigated. In vitro dissolution studies were performed using USP XXIII apparatus I at pH 6.2. Release profiles were evaluated according to first order, Higuchi square root of time and Hixson-Crowell cube root models. The best fit was found with the square root of time model (r(2) = 0.991) for the microspheres (125-250 mum) prepared in 1:4:1 drug-lipid-copolymer ratio using stearyl alcohol. With a further regression analysis, an excellent equation (Release % = - 10.721 + 42.549* roott - 4.027*t) was developed for empirical drug estimation (r(2) = 0.998). (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:99 / 104
页数:6
相关论文
共 19 条
[1]   PROCESSING FACTORS AFFECTING PARTICLE-SIZE AND IN-VITRO DRUG-RELEASE OF SUSTAINED-RELEASE IBUPROFEN MICROSPHERES [J].
ALKASSAS, RS ;
GILLIGAN, CA ;
PO, ALW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 94 (1-3) :59-67
[2]  
*AM PHARM ASS PHAR, 1986, HDB PHARM EXC AM PHA
[3]  
Budavari S., 1996, MERCK INDEX, V12th
[4]  
DRAPER NR, 1981, APPL REGRESSION ANAL, P33
[5]  
Eis MJ, 1998, AM J GASTROENTEROL, V93, P120
[6]   Microporous membrane drug delivery system for indomethacin [J].
Elchidana, PA ;
Deshpande, SG .
JOURNAL OF CONTROLLED RELEASE, 1999, 59 (03) :279-285
[7]   Release characteristics of implantable cylindrical polyethylene matrices [J].
Ertan, G ;
Karasulu, E ;
Demirtas, D ;
Arici, M ;
Guneri, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49 (03) :229-235
[8]  
GOODMAN LS, 1980, PHARMACOL BASIS THER, P705
[9]  
HASSANZADEH MK, 1999, INDIAN DRUGS, V36, P253